GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q4 2023

SEC EDGAR SourceSEC Filings

Top Holdings44 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

THE CIGNA GROUP

2.1M$641.6M13.7%$235.61+22.52%
21 qtrssince 2018-Q4
Increased
82

TENET HEALTHCARE CORP

7.7M$585.1M12.5%$35.04+115.65%
21 qtrssince 2018-Q4
Increased
70
IWMIWM
PUT

ISHARES RUSSELL 2000 ETF ETF

1.6M$318.6M6.8%
Increased

DXC TECHNOLOGY CO

13M$297.5M6.4%$34.05-32.84%
21 qtrssince 2018-Q4
Increased
78

UNIVERSAL HEALTH SERVICES-B

1.7M$259.4M5.5%$141.08+7.17%
5 qtrssince 2022-Q4
Decreased
0

GLOBAL PAYMENTS INC

1.9M$247.4M5.3%$149.30-16.69%
13 qtrssince 2020-Q4
Increased
64

CLARIVATE PLC

24.7M$228.3M4.9%$9.260.00%
7 qtrssince 2022-Q2
Increased
69

CORTEVA INC

4.7M$225.2M4.8%$48.19-2.69%
17 qtrssince 2019-Q4
Increased
92

ALIGHT INC

18.2M$155.3M3.3%$8.05+1.21%
6 qtrssince 2022-Q3
Increased
63

MCKESSON CORP

326,896$151.3M3.2%$144.46+217.66%
21 qtrssince 2018-Q4
Decreased
0

FISERV INC

943,277$125.3M2.7%$106.06+25.24%
18 qtrssince 2019-Q3
Decreased
0

UBER TECHNOLOGIES INC

2M$120.9M2.6%$41.79+47.32%
11 qtrssince 2021-Q2
Decreased
0

EXPEDIA GROUP INC

701,261$106.4M2.3%$96.43+56.14%
6 qtrssince 2022-Q3
Decreased
0

AMAZON.COM INC

694,077$105.5M2.3%$124.49+22.05%
4 qtrssince 2023-Q1
Decreased
0

MYRIAD GENETICS INC

5.3M$101.1M2.2%$18.94+1.04%
18 qtrssince 2019-Q3
Increased
69

BROOKDALE SR LIVING INC

16.9M$98.6M2.1%$4.69+24.00%
21 qtrssince 2018-Q4
Decreased
0

VALVOLINE INC

2.3M$87.2M1.9%$29.39+27.87%
8 qtrssince 2022-Q1
Decreased
0

ELEMENT SOLUTIONS INC

3.8M$87.1M1.9%$17.19+31.16%
20 qtrssince 2019-Q1
Increased
62

US FOODS HOLDING CORP

1.8M$79.6M1.7%$36.59+24.11%
9 qtrssince 2021-Q4
Decreased
0

HCA HOLDINGS INC

251,516$68.1M1.5%$172.02+54.97%
21 qtrssince 2018-Q4
Decreased
0
$4.7B
AUM
44
Positions
Q4 2023
Filing
Rating · 4.0
Quarterly Portfolio Change
+0%Q3'22$4B+13%Q4'22$4.5B+1%Q1'23$4.6B-3%Q2'23$4.4B-0%Q3'23$4.4B+6%Q4'23$4.7B
Activity profile
$ moved · Q4'23
New7%Increased44%Decreased11%Exited38%
Composition
Equity vs derivatives
Equity92%Puts7%Calls1%
Holding period
Avg 2.6 years
<1Q14%1-4Q16%1-2Y11%2Y+59%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $4.7B across 44 positions as of Q4 2023. Top holdings: CI (13.7%), THC (12.5%), IWM (6.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q4 2023 Summary

Active quarter - 6 new positions, 12 exits, 14 increased. Top move: CTVA (INCREASED, conviction 92). Portfolio: $4.7B across 44 positions.

Top holdings by portfolio weight

Total AUM$4B
CI13.72%
THC12.51%
DXC6.36%
UHS5.55%
GPN5.29%
CLVT4.88%
CTVA4.81%
ALIT3.32%
MCK3.24%
FISV2.68%
Other2.59%

Portfolio allocation by GICS sector

Sectors8
Healthcare49.29%
Technology19.70%
Consumer Cyclical7.83%
Industrials7.57%
Basic Materials7.32%
Unknown4.00%
Communication Services2.44%
Consumer Defensive1.87%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Technology
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record72
Conviction49
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PAYMENTS INC
Q2 2025 Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON.COM INC
Q3 2025 Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used